AVIR
Price
$3.90
Change
+$0.16 (+4.28%)
Updated
Jul 25 closing price
Capitalization
333.76M
10 days until earnings call
AXON
Price
$735.01
Change
+$25.75 (+3.63%)
Updated
Jul 25 closing price
Capitalization
57.22B
8 days until earnings call
Interact to see
Advertisement

AVIR vs AXON

Header iconAVIR vs AXON Comparison
Open Charts AVIR vs AXONBanner chart's image
Atea Pharmaceuticals
Price$3.90
Change+$0.16 (+4.28%)
Volume$447.74K
Capitalization333.76M
Axon Enterprise
Price$735.01
Change+$25.75 (+3.63%)
Volume$723.68K
Capitalization57.22B
AVIR vs AXON Comparison Chart in %
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. AXON commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Buy and AXON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AVIR: $3.90 vs. AXON: $735.01)
Brand notoriety: AVIR and AXON are both not notable
AVIR represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: AVIR: 116% vs. AXON: 125%
Market capitalization -- AVIR: $333.76M vs. AXON: $57.22B
AVIR [@Biotechnology] is valued at $333.76M. AXON’s [@Aerospace & Defense] market capitalization is $57.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $288B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B. The average market capitalization across the [@Aerospace & Defense] industry is $20.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileAXON’s FA Score has 2 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • AXON’s FA Score: 2 green, 3 red.
According to our system of comparison, AXON is a better buy in the long-term than AVIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 6 TA indicator(s) are bullish while AXON’s TA Score has 5 bullish TA indicator(s).

  • AVIR’s TA Score: 6 bullish, 3 bearish.
  • AXON’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AVIR is a better buy in the short-term than AXON.

Price Growth

AVIR (@Biotechnology) experienced а +16.07% price change this week, while AXON (@Aerospace & Defense) price change was -2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -1.28%. For the same industry, the average monthly price growth was +8.26%, and the average quarterly price growth was +44.60%.

Reported Earning Dates

AVIR is expected to report earnings on Nov 06, 2025.

AXON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (-1.28% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($57.2B) has a higher market cap than AVIR($334M). AXON YTD gains are higher at: 23.672 vs. AVIR (16.418). AXON has higher annual earnings (EBITDA): 398M vs. AVIR (-161.77M). AXON has more cash in the bank: 2.37B vs. AVIR (425M). AVIR has less debt than AXON: AVIR (1.45M) vs AXON (2.05B). AXON has higher revenues than AVIR: AXON (2.23B) vs AVIR (0).
AVIRAXONAVIR / AXON
Capitalization334M57.2B1%
EBITDA-161.77M398M-41%
Gain YTD16.41823.67269%
P/E RatioN/A177.11-
Revenue02.23B-
Total Cash425M2.37B18%
Total Debt1.45M2.05B0%
FUNDAMENTALS RATINGS
AVIR vs AXON: Fundamental Ratings
AVIR
AXON
OUTLOOK RATING
1..100
8068
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
959
SMR RATING
1..100
9554
PRICE GROWTH RATING
1..100
4441
P/E GROWTH RATING
1..100
9510
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for AXON (97). This means that AVIR’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (9) in the Biotechnology industry is significantly better than the same rating for AVIR (95). This means that AXON’s stock grew significantly faster than AVIR’s over the last 12 months.

AXON's SMR Rating (54) in the Biotechnology industry is somewhat better than the same rating for AVIR (95). This means that AXON’s stock grew somewhat faster than AVIR’s over the last 12 months.

AXON's Price Growth Rating (41) in the Biotechnology industry is in the same range as AVIR (44). This means that AXON’s stock grew similarly to AVIR’s over the last 12 months.

AXON's P/E Growth Rating (10) in the Biotechnology industry is significantly better than the same rating for AVIR (95). This means that AXON’s stock grew significantly faster than AVIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRAXON
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HEQ10.630.04
+0.38%
John Hancock Diversified Income Fund
MMCA21.20N/A
N/A
NYLI MacKay California Muni Intmdt ETF
LIAJ190.39N/A
N/A
LifeX 2053 Infl-Prt Longevity Inc ETF
SIXH38.81-0.10
-0.25%
ETC 6 Meridian Hdg Eq-Idx Opt Strat ETF
VSGX66.61-0.19
-0.28%
Vanguard ESG International Stock ETF

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
+4.28%
AXON - AVIR
46%
Loosely correlated
+3.63%
XENE - AVIR
46%
Loosely correlated
-2.29%
IDYA - AVIR
44%
Loosely correlated
-1.33%
ZNTL - AVIR
43%
Loosely correlated
N/A
IMNM - AVIR
42%
Loosely correlated
-3.29%
More